Overexpression of transforming growth factor β type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line

Cell Growth and Differentiation

Volumn 8, Issue 8, 1997, Pages 921-926

  Okamoto, Masato ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GROWTH REGULATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; CARCINOMA; CELL DIVISION; GENE EXPRESSION; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 0030858641     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Massagué, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
2. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M., and Massagué, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science (Washington DC), 260: 536-539, 1993.
3. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 90: 770-774, 1993.
4. Arteaga, C. L., Tandon, A. K., Von Hoff, D. D., and Osborne, C. K. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48: 3898-3904, 1988.
5. Kimchi, A., Wang, X. F., Weinberg, R. A., Cheifetz, S., and Massagué, J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science (Washington DC), 240: 196-240, 1988.
6. Wakefield, L. M., and Sporn, M. B. Suppression of carcinogenesis: a role for TGF-β and related molecules in prevention of cancer. Immunol. Ser., 51: 217-243, 1990.
7. Shipley, G. D., Pittelkow, M. R., Wille, J. J., Scott, R. E., and Moses, H. L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res., 46: 2068-2071, 1986.
8. Morton, D. M., and Barrack, E. R. Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res., 55: 2596-2602, 1995.
9. Massagué, J. Receptors for TGF-β family. Cell, 69: 1067-1070, 1992.
10. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massagué, J. TGFβ signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
11. Wang, X. F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., and Weinberg, R. A. Expression cloning and characterization of the TGF-β type III receptor. Cell, 67: 797-805, 1991.
12. Kawamata, H., Azuma, M., Kameyama, S., Nan, L., and Oyasu, R. Effect of epidermal growth factor/transforming growth factor-α and transforming growth factor-β1 on growth in vitro of rat urinary bladder carcinoma cells. Cell Growth & Differ., 3: 819-825, 1992.
13. Kawamata, H., Kameyama, S., Nan, L., Kawai, K., and Oyasu, R. Effect of epidermal growth factor and transforming growth factor-β1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Int. J. Cancer, 55: 968-973, 1993.
14. Reynisdottir, I., Polyak, K., Iavarone, A., and Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
15. Ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C, H. Characterization of type I receptor for transforming growth factor-β and activin. Science (Washington DC), 264: 101-104, 1994.
16. Massagué, J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell, 85: 947-950, 1996.
17. Zhang, Y., Feng, X-H., Wu, R-U., and Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature (Lond.), 383: 168-172, 1996.
18. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
19. Barret, M. T., Schutte, M., Kern, S. E., and Reid, B. J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res., 56: 4351-4353, 1996.
20. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinsrein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 277: 350-353, 1996.
21. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., and Sporn, M. B. Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J. Biol. Chem., 267: 2588-2593, 1992.
22. Sun, L., Wu, G., Willson, J. K. B., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., and Brattain, M. G. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269: 26449-26445, 1994.
23. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
24. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J. H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
25. Carcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., and Massagué, J. Type-I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor-β and activin. Mol. Cell. Biol., 14: 3810-3821, 1994.
26. Johnson, D. W., Qumsiyeh, M., Benkhalifa, M., and Marchuk, D. K. Assignment of human transforming growth factor-β type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics, 28: 356-357, 1996.
27. Miyao, M., Tsai, Y. C., Lerner, S. P., Olumi, A. F., Spruck, C. H., III, Gonzalez-Zulueta, M., Nichols, P. W., Skinner, D. G., and Jones, P. A. Role of chromosome 9 in human bladder cancer. Cancer Res., 53: 4066-4070, 1993.
28. Bassing, C. H., Yinging, J. M., Howe, D. J., Wang, T., Wu He, W., Gustafson, M. L., Shah, P., Donahoe, P. K., and Wang, X. F. A transforming growth factor β type I receptor that signals to activate gene expression. Science (Washington DC), 263: 87-89, 1994.
29. Tsuchida, K., Lewis, A. K., Mathews, L. S., and Vale, W. W. Molecular characterization of rat transforming growth factor-β type II receptor. Biochem. Biophys. Res. Commun., 191: 790-795, 1993.
30. Okamoto, M., Kawamata, H., Kawai, K., and Oyasu, R. Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin-6. Cancer Res., 55: 4581-4585, 1995.
31. Yamashita, H., Dijke, P. T., Franzen, P., Miyazono, K., and Heldin, C. H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269: 20172-20178, 1994.
32. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.